Marketing-authorisation holder · United States
Sanofi Aventis Us
118 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
118 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 118
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACCURBRON150mg/15ml · Syrup | Theophylline | United States | Not marketed | |
| ACTHAR25 units/vial | 40 units/vial · Injectable | Corticotropin | United States | Not marketed | 1950 |
| ADLYXIN0.15mg/3ml (0.05mg/ml) | 0.3mg/3ml (0.1mg/ml) · Solution | Lixisenatide | United States | Marketed | 2016 |
| ADMELOG1000 units/10ml (100 units/ml) | 300 units/3ml (100 units/ml) · Solution | Insulin lispro | United States | Marketed | 2017 |
| ADMELOG SOLOSTAR300 units/3ml (100 units/ml) · Solution | Insulin lispro | United States | Marketed | 2017 |
| AMARYL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Glimepiride | United States | Not marketed | 1995 |
| APIDRA1000 units/10ml (100 units/ml) | 300 units/3ml (100 units/ml) · Injectable | Insulin glulisine recombinant | United States | Marketed | 2004 |
| APIDRA SOLOSTAR300 units/3ml · Injectable | Insulin glulisine recombinant | United States | Marketed | 2004 |
| ARALEN500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Chloroquine | United States | Not marketed | 1949 |
| ARALEN HYDROCHLORIDE40mg base/ml · Injectable | Chloroquine | United States | Not marketed | 1949 |
| ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE300mg base; 45mg base · Tablet | Chloroquine, Primaquine | United States | Not marketed | 1968 |
| ARAVA100mg | 10mg | 20mg · Tablet | Leflunomide | United States | Marketed | 1998 |
| AUBAGIO14mg | 7mg · Tablet | Teriflunomide | United States | Marketed | 2012 |
| AVALIDE12.5MG; 150MG | 12.5MG; 300MG | 12.5MG; 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG; 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Hydrochlorothiazide, Irbesartan | United States | Marketed | 1997 |
| AVAPRO150mg | 300mg | 75mg · Tablet | Irbesartan | United States | Marketed | 1997 |
| AZOLID100mg · Capsule | Phenylbutazone | United States | Not marketed | 1981 |
| AZOLID100mg · Tablet | Phenylbutazone | United States | Not marketed | |
| BENDECTIN10MG; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Doxylamine, Vitamin b6 | United States | Not marketed | 1956 |
| BRICANYL0.2mg/inh · Aerosol, metered | Terbutaline | United States | Not marketed | 1985 |
| BRICANYL1mg/ml · Injectable | Terbutaline | United States | Not marketed | 1974 |
| BRICANYL2.5mg | 5mg · Tablet | Terbutaline | United States | Not marketed | 1975 |
| BRONKODYL100mg | 200mg · Capsule | Theophylline | United States | Not marketed | |
| BRONKOMETER0.34mg/inh · Aerosol, metered | Isoetharine | United States | Not marketed | |
| BRONKOSOL0.25% | 1% · Solution | Isoetharine | United States | Not marketed | |
| BRYREL500mg base/5ml · Syrup | Piperazine | United States | Not marketed |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 118 | 118 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.